Registro:

Referencias:

• Blake, D.J., Weir, A., Newey, S.E., Davies, K.E., Function and genetics of dystrophin and dystrophin-related proteins in muscle (2002) Physiol Rev, 82, pp. 291-329
• Sgambato, A., Migaldi, M., Montanari, M., Camerini, A., Brancaccio, A., Rossi, G., Cangiano, R., Cittadini, A., Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression (2003) Am J Pathol, 162, pp. 849-860
• Korner, H., Epanchintsev, A., Berking, C., Schuler-Thurner, B., Speicher, M.R., Menssen, A., Hermeking, H., Digital karyotyping reveals frequent inactivation of the dystrophin/DMD gene in malignant melanoma (2007) Cell Cycle, 6, pp. 189-198
• Schmidt, W.M., Uddin, M.H., Dysek, S., Moser-Thier, K., Pirker, C., Hoger, H., Ambros, I.M., Bittner, R.E., DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in muscular dystrophies (2011) PLoS genetics, 7
• Hosur, V., Kavirayani, A., Riefler, J., Carney, L.M., Lyons, B., Gott, B., Cox, G.A., Shultz, L.D., Dystrophin and dysferlin double mutant mice: a novel model for rhabdomyosarcoma (2012) Cancer genetics, 205, pp. 232-241
• Wang, Y., Marino-Enriquez, A., Bennett, R.R., Zhu, M., Shen, Y., Eilers, G., Lee, J.C., Fletcher, C.D., Dystrophin is a tumor suppressor in human cancers with myogenic programs (2014) Nat Genet, 46, pp. 601-606
• Barrett, T., Wilhite, S.E., Ledoux, P., Evangelista, C., Kim, I.F., Tomashevsky, M., Marshall, K.A., Davis, S., NCBI GEO: archive for functional genomics data sets update (2013) Nucleic acids research, 41, pp. D991-D995
• Edgar, R., Domrachev, M., Lash, A.E., Gene Expression Omnibus: NCBI gene expression and hybridization array data repository (2002) Nucleic acids research, 30, pp. 207-210
• Gentleman, R.C., Carey, V.J., Bates, D.M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Huber, W., Bioconductor: open software development for computational biology and bioinformatics (2004) Genome biology, 5, p. R80
• Huber, W., Carey, V.J., Gentleman, R., Anders, S., Carlson, M., Carvalho, B.S., Bravo, H.C., Hansen, K.D., Orchestrating highthroughput genomic analysis with Bioconductor (2015) Nature methods, 12, pp. 115-121
• Irizarry, R.A., Hobbs, B., Collin, F., Beazer-Barclay, Y.D., Antonellis, K.J., Scherf, U., Speed, T.P., Exploration, normalization, and summaries of high density oligonucleotide array probe level data (2003) Biostatistics, 4, pp. 249-264
• Ritchie, M.E., Phipson, B., Wu, D., Hu, Y., Law, C.W., Shi, W., Smyth, G.K., limma powers differential expression analyses for RNA-sequencing and microarray studies (2015) Nucleic acids research, 43
• Cerami, E., Gao, J., Dogrusoz, U., Gross, B.E., Sumer, S.O., Aksoy, B.A., Jacobsen, A., Schultz, N., The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data (2012) Cancer discovery, 2, pp. 401-404
• Gao, J., Aksoy, B.A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S.O., Sun, Y., Schultz, N., Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal (2013) Science signaling, 6
• Pantaleo, M.A., Astolfi, A., Urbini, M., Fuligni, F., Saponara, M., Nannini, M., Lolli, C., Biasco, G., Dystrophin deregulation is associated with tumor progression in KIT/PDGFRA mutant gastrointestinal stromal tumors (2014) Clinical sarcoma research, 4, p. 9
• Stephens, N.A., Skipworth, R.J., Gallagher, I.J., Greig, C.A., Guttridge, D.C., Ross, J.A., Fearon, K.C., Evaluating potential biomarkers of cachexia and survival in skeletal muscle of upper gastrointestinal cancer patients (2015) Journal of cachexia, sarcopenia and muscle, 6, pp. 53-61
• Nikitin, E.A., Malakho, S.G., Biderman, B.V., Baranova, A.V., Lorie, Y.Y., Shevelev, A.Y., Peklo, M.M., Sudarikov, A.B., Expression level of lipoprotein lipase and dystrophin genes predict survival in B-cell chronic lymphocytic leukemia (2007) Leukemia & lymphoma, 48, pp. 912-922
• Tan, S., Tan, S., Chen, Z., Cheng, K., Chen, Z., Wang, W., Wen, Q., Zhang, W., Knocking down Dp71 expression in A549 cells reduces its malignancy in vivo and in vitro (2016) Cancer investigation, 34, pp. 16-25
• Talantov, D., Mazumder, A., Yu, J.X., Briggs, T., Jiang, Y., Backus, J., Atkins, D., Wang, Y., Novel genes associated with malignant melanoma but not benign melanocytic lesions (2005) Clin Cancer Res, 11, pp. 7234-7242
• Chandran, U.R., Ma, C., Dhir, R., Bisceglia, M., Lyons-Weiler, M., Liang, W., Michalopoulos, G., Monzon, F.A., Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process (2007) BMC Cancer, 7, p. 64
• Yu, Y.P., Landsittel, D., Jing, L., Nelson, J., Ren, B., Liu, L., McDonald, C., Luo, J.H., Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy (2004) J Clin Oncol, 22, pp. 2790-2799
• Landi, M.T., Dracheva, T., Rotunno, M., Figueroa, J.D., Liu, H., Dasgupta, A., Mann, F.E., Pesatori, A.C., Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival (2008) PLoS One, 3
• Lu, T.P., Tsai, M.H., Lee, J.M., Hsu, C.P., Chen, P.C., Lin, C.W., Shih, J.Y., Chuang, E.Y., Identification of a novel biomarker, SEMA5A, for non-small cell lung carcinoma in nonsmoking women (2010) Cancer Epidemiol Biomarkers Prev, 19, pp. 2590-2597
• Kabbout, M., Garcia, M.M., Fujimoto, J., Liu, D.D., Woods, D., Chow, C.W., Mendoza, G., Kadara, H., ETS2 mediated tumor suppressive function and MET oncogene inhibition in human non-small cell lung cancer (2013) Clin Cancer Res, 19, pp. 3383-3395
• Casey, T., Bond, J., Tighe, S., Hunter, T., Lintault, L., Patel, O., Eneman, J., Plaut, K., Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer (2009) Breast Cancer Res Treat, 114, pp. 47-62
• Merdad, A., Karim, S., Schulten, H.J., Dallol, A., Buhmeida, A., Al-Thubaity, F., Gari, M.A., Al-Qahtani, M.H., Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis (2014) Anticancer Res, 34, pp. 1355-1366
• Badea, L., Herlea, V., Dima, S.O., Dumitrascu, T., Popescu, I., Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia (2008) Hepatogastroenterology, 55, pp. 2016-2027
• Sole, X., Crous-Bou, M., Cordero, D., Olivares, D., Guino, E., Sanz-Pamplona, R., Rodriguez-Moranta, F., Moreno, V., Discovery and validation of new potential biomarkers for early detection of colon cancer (2014) PLoS One, 9
• Closa, A., Cordero, D., Sanz-Pamplona, R., Sole, X., Crous-Bou, M., Pare-Brunet, L., Berenguer, A., Moreno, V., Identification of candidate susceptibility genes for colorectal cancer through eQTL analysis (2014) Carcinogenesis, 35, pp. 2039-2046
• Griesinger, A.M., Birks, D.K., Donson, A.M., Amani, V., Hoffman, L.M., Waziri, A., Wang, M., Foreman, N.K., Characterization of distinct immunophenotypes across pediatric brain tumor types (2013) J Immunol, 191, pp. 4880-4888
• Brune, V., Tiacci, E., Pfeil, I., Doring, C., Eckerle, S., van Noesel, C.J., Klapper, W., Kuppers, R., Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis (2008) The Journal of experimental medicine, 205, pp. 2251-2268
• Giefing, M., Winoto-Morbach, S., Sosna, J., Doring, C., Klapper, W., Kuppers, R., Bottcher, S., Schutze, S., Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma show alterations of genes encoding the NADPH oxidase complex and impaired reactive oxygen species synthesis capacity (2013) PLoS One, 8
• Cramer-Morales, K., Nieborowska-Skorska, M., Scheibner, K., Padget, M., Irvine, D.A., Sliwinski, T., Haas, K., Wasik, M.A., Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile (2013) Blood, 122, pp. 1293-1304
• Gutierrez, A., Jr., Tschumper, R.C., Wu, X., Shanafelt, T.D., Eckel-Passow, J., Huddleston, P.M., III, Slager, S.L., Jelinek, D.F., LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis (2010) Blood, 116, pp. 2975-2983
• Wang, L., Shalek, A.K., Lawrence, M., Ding, R., Gaublomme, J.T., Pochet, N., Stojanov, P., Sievers, Q.L., Somatic mutation as a mechanism of Wnt/beta-catenin pathway activation in CLL (2014) Blood, 124, pp. 1089-1098
• Von Roemeling, C.A., Radisky, D.C., Marlow, L.A., Cooper, S.J., Grebe, S.K., Anastasiadis, P.Z., Tun, H.W., Copland, J.A., Neuronal pentraxin 2 supports clear cell renal cell carcinoma by activating the AMPA-selective glutamate receptor-4 (2014) Cancer Res, 74, pp. 4796-4810
• Stirewalt, D.L., Meshinchi, S., Kopecky, K.J., Fan, W., Pogosova-Agadjanyan, E.L., Engel, J.H., Cronk, M.R., Radich, J.P., Identification of genes with abnormal expression changes in acute myeloid leukemia (2008) Genes, chromosomes & cancer, 47, pp. 8-20

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------